Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nexium

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Nexium was produced by AstraZeneca and Daiichi Sankyo.

Leading AstraZeneca’s return to growth in Europe

Leading AstraZeneca’s return to growth in Europe

doldrums due to the expiry of old blockbusters such as Nexium and Crestor.

AstraZeneca’s oncology renaissance

AstraZeneca’s oncology renaissance This saw phase 3 flops of drugs for stroke, prostate cancer and depression – failures that dented confidence in the firm as patent expiries for its blockbusters Crestor and Nexium loomed on

China: AstraZeneca’s new engine for growth and innovation

China: AstraZeneca’s new engine for growth and innovation years for AZ to return to top-line growth after the patent loss of blockbuster brands such as Nexium and Crestor.

AZ expects return to growth this year after 2017 decline

AZ expects return to growth this year after 2017 decline to $2.6bn, although the cumulative effect of patent expiries - which also affect antipsychotic Seroquel XR (quetiapine) and gastrointestinal drug Nexium (esomeprazole) - are starting to dissipate.

AZ sells Zurampic rights to Gruenenthal for $230m

AZ sells Zurampic rights to Gruenenthal for $230m light of the loss of patent protection for blockbuster brands such as cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal diseases.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...